Coherus Biosciences Inc (CHRS) Stock Forecast & Predictions

Coherus Biosciences Inc CHRS: $14.63

333 Twin Dolphin Dr Ste 600, Redwood City, California, US. | Sector: Manufacturing | Exchange: NASDAQ/NMS (GLOBAL MARKET) | Web:

  • Market Cap$1.08B
  • Change (52 Weeks)-9.56%
  • Low (52 Weeks)$13.53
  • Coherus Biosciences Inc (CHRS) Forecast Based on Technical Analysis

    Based on 16 Technical Indicators where 0.00% are on Buy, 50.00% on Sell, and 50.00% Neutral.

    According to the market data, Coherus Biosciences Inc (CHRS) stock price is $14.63 and the 52 weeks low is $13.53, which means the Coherus Biosciences Inc stock price is down -9.56% in the last 12 months.

    Coherus Biosciences Inc (CHRS) Stock Price is not Trending currently as per the Weekly Chart, which means the price may range between specific high and low levels for the next few months, unless some significant changes take place in the market performance or news.

    Technical Indicators are algorithms that are used mostly by Technical traders to predict the price action of a stock.

    Based on our analysis of 16 technical indicators, 0.00% are indicating that CHRS Stock price might rise further, 50.00% indicating that CHRS Stock price might fall, and 50.00% are in a neutral position.

    Based on these technical algorithms, overall CHRS stock price has a Neutral Signal, which means the stock price has the potential to move either up or down, depending on the nature of consolidating market phase, since majority of indicators are providing a neutral signal.

    Coherus Biosciences Inc (CHRS) Stock Forecast By Analysts

    Strong Buy
    Analysts Recommendations for Coherus Biosciences Inc (CHRS) is based on 15 Institutional Analyst Ratings where 66.67% are on Strong Buy, 20.00% on Moderate Buy, 13.33% remains on Hold, 0.00% are on Moderate Sell and 0.00% are on Strong Sell.

    Out of 15 Institutional Analysts, majority recommended CHRS stock as Strong Buy. Since most investors and traders follow analyst ratings closely, this can be a potentially driving factor for the future stock price of Coherus Biosciences Inc.

    Coherus Biosciences Inc (CHRS) Stock Price Prediction By Analysts

    $28.1892.6% Upside
    Updated: 2021-04-22 00:00:00

    The Average Price target for CHRS set by the institutional analysts is $28.18 where High Estimate is $36.75, Median $28.05 and Low $18.18.

    The average price target for CHRS by Institutional Analysts is $28.18, which is 92.6% Upside from the current price. So according to the Institutional Analysts, CHRS Stock might be a bit undervalued at this stage and there’s potential for upside.

    However, although Institutional Analysts set their price targets after extensive research, they’re not always correct. After all, the market is mostly driven by investors speculation and emotion than just concrete numbers.

    Coherus Biosciences Inc (CHRS) Stock Forecast Based on News Sentiment

    Based on 1 articles published Last Week, where 100.00% are Bullish and 0.00% are Bearish.

    According to the news articles published last week, most journalists and bloggers talked positively about CHRS, it shows that Coherus Biosciences Inc had a 100.00% positive news coverage.

    Positive news coverage usually affects short-term price of a stock, so this positive coverage provides an indication that CHRS stock price may surge in the next few weeks.

    Coherus Biosciences Inc (CHRS) Stock Forecasts By Institutional Analysts

    HC Wainwright & Co.BuyMaintained
    HC Wainwright & Co.BuyMaintained
    Truist SecuritiesBuyMaintained
    HC Wainwright & Co.BuyMaintained
    B of A SecuritiesNeutralInitiated
    SunTrust Robinson HumphreyBuyInitiated
    H.C. WainwrightBuyReiterated
    JP MorganOverweightMaintained
    H.C. WainwrightBuyInitiated
    H.C. WainwrightBuyInitiated
    Maxim GroupBuyMaintained
    Maxim GroupBuyMaintained
    BMO CapitalOutperformInitiated
    Standpoint ResearchSpeculative BuyInitiated
    Maxim GroupBuyInitiated
    Credit SuisseOutperformInitiated
    JP MorganOverweightMaintained
    Credit SuisseOutperformInitiated
    Cowen & Co.OutperformInitiated

    Coherus Biosciences Inc (CHRS) Stock Earning Per Share (EPS) Forecast / Estimate

    The average consensus EPS for CHRS is $0.142 with a high estimate of $0.284 and Low of $0.059 for the period 2021-06-30 and based on 10 Institutional Analysts.

    Last Quarter


    The latest average Earning Per Share Estimate for Coherus Biosciences Inc is $0.14, which is lower than CHRS's last EPS, $0.33. This means that Analysts are expecting Coherus Biosciences Inc to report lower earnings. This can drive share prices lower since the investors have negative sentiment about market performance of Coherus Biosciences Inc.

    Earning Per Share (EPS) History


    What is Analyst Ratings & Price Targets?

    The analysts provide Buy, Sell or Hold ratings after extensive research of a companies financial reports, listening to conference calls and some of them even get in contact with upper management of the company to get an overall picture of operation.

    Although institutional Analyst’s are not always correct, their ratings are followed by millions of traders around the world and they can heavily influence trading activities for a company.

    As a retail investor, going through analyst ratings will instantly provide you an idea if the stock is worth buying. Top Analysts also provide their price targets. It’s a prediction of where the stock price might go based on their analysis.

    The best way to analyze price targets is to combined average price targets of major analysts. If the average price target is much higher than the current price of the stock, then the probability of a stock going up is also high.

    What is Technical Analysis?

    Technical Analysis refers to analyzing a stock's price over a period of time. In the financial market, past price patterns are one of the strongest indicators of an asset's future performance.

    In easier terms, millions of traders use Live Charts to watch the stock prices, it is actually a single source of truth for most traders. When a stock's price reaches a significant price level/pattern in the chart, millions of traders take buy/sell positions from those levels.

    As a regular investor, one of the easiest ways to check technical analysis of a stock is through Technical Indicators. Technical Indicators are programmed algorithms that monitor price changes in the Charts and indicate Buy/Sell based on market conditions.

    Some Technical Indicators can be very powerful (e.g SMA) and some can be pretty useless. Stock research tools like iTradely heavily simplify the technical analysis process for the investors by showing Buy/Sell/Neutral ratings combined from 17 powerful technical indicators, all in one page.

    What is Earnings Per Share (EPS) and Why is it Important?

    EPS, or Earning Per Share, can tell a lot about a stock’s performance. It’s calculated by dividing a company’s profit by the number of outstanding shares of its common stocks.

    In layman’s term, earnings is an indicator of a company’s profitability. Higher the earnings, the more profitable a company is.
    Some traders pick stocks solely based on EPS or earnings Analysis, it is a very powerful indicator of a stock’s price.

    Before you buy a stock, check the company’s earnings History and Surprises. A Surprise happens when a company reports a much higher or lower actual earnings/EPS than the forecasted earnings/EPS.

    If a company reports higher EPS surprises consistently, analysts keep raising their estimates, traders become more confident in the company, driving the share price higher.

    What is Stock Sentiment?

    Stock Sentiment refers to how people speculating about the stock or what kind of trading position investors are often taking.

    There are different kinds of sentiments you can find online for a company, this includes Investor Sentiment (Percentage of investors buying or selling), News Sentiment (Is the company getting positive or negative impressions from the Press?), Social Sentiment (The overall trends about the company in social media, is it negative or positive?).